New Clinical Trial for July 2015 at The Oncology Institute of Hope and Innovation

July 31, 2015 - PRLog -- If you would like more information or are interested
in referring a patient to one of these trials,
please contact our office at (562) 869-1201

         The Oncology Institute of Hope and Innovation is proud to have access to the latest research, technology and treatment options, including clinical trials for eligible patients.

Benefits of participating in a clinical trial:

Clinical trials that are well-designed and well-executed are the best approach for eligible participants to:

Play an active role in their health care
Gain access to new research treatments before they are widely available
Obtain expert medical care at leading health care facilities during the trial
Help others by contributing to medical research

Recently opened trial at all of our sites:

         A Phase 1b/II, multicenter, single arm trial to assess the efficacy, safety, and pharmacokinetics (PK) of MSC2156119J as monotherapy in subjects with MET+ advanced hepatocellular carcinoma (HCC) with Child Pugh Class A liver function who have failed sorafenib treatment.

Your patient participating in a clinical trial can aid you directly by giving you access to potentially helpful treatments before they are available to the general public. Your patient's participation may mean that your patient may be among the first to benefit from the latest cutting-edge research as it moves out of the laboratory and into doctors' hands.

If you have patients who you feel may qualify for this trial, or have questions regarding eligibility, please contact any one of our office locations to schedule an evaluation.  We look forward to working with you.

Anaheim: (714) 399-0620
Covina: (626) 283-5183
Downey: (562) 869-1201
Glendale: (818) 334-5425
Long Beach: (562) 232-0550
Los Angeles: (323)284-4077
Lynwood: (310) 667-4000
Montebello: (323) 278-4400
Santa Ana: (714) 542-0102
Torrance: (310) 935-4525
 Upland (909) 906-1519
Whittier: (562) 698-6888